Another study using ovarian cancer cells demonstrated that the sensitivity of the cells to auranofin is enhanced by BRCA1 deficiency; BRCA1 is involved in DNA repair and in regulating the stability of anti-oxidant transcription factor Nrf2 via protein–protein interaction. Here, BRCA1 is linked to ovarian cancer.